Vegalab, Inc. ("the Company"), (OTCQB: VEGL), today announced the Company has signed a distribution agreement with Van Iperen International B.V., the foremost specialty fertilizer and high performance agricultural solutions producer in The Netherlands. Van Iperen Group, a company with impressive continuous growth, recorded income (turnover) of US $278 Million in 2017. According the agreement, Vegalab will begin to distribute Van Iperen International’s high tech Dutch agricultural products beginning calendar year 2019.
Van Iperen International B.V., is a privately held, family-owned company with over 100 years of experience providing high-tech solutions to the Dutch agriculture sector. According to the Dutch Ministry of Agriculture, Nature and Food Quality, The Netherlands is one of the world’s largest agricultural producers, exporting 65 billion Euros worth of vegetables, fruit, flowers, meat and dairy products each year. With 150 employees, of which 40 are extensively trained agronomists, Van Iperen’s team’s comprehensive knowledge of crop needs, will help advance plant yields in American markets. Vegalab’s sales and marketing force will educate American growers on best practices and advanced applications of Van Iperen’s products that have a successful track record of improving the output of many Dutch farms.
Erik van den Bergh, CEO and Managing Director of Van Iperen International, stated, “We are excited to have the opportunity to work with Vegalab as a partner in the United States. We have tailored our products to maximize production and consistent with the mission of Vegalab, we are committed to the environment and sustainable agriculture. We will work together to supply better, earth-friendly products which, improve overall produce yields, year after year.”
David Selakovic, CEO of Vegalab, said, “We have been in conversations with the team at Van Iperen International for some time. The Vegalab management team was widely aware the Netherlands has become an agricultural powerhouse and their farmers have developed many of the most advanced farming techniques deployed worldwide. The team at Van Iperen and their products are well-known across the Netherlands, however; their specialty fertilizers and solutions, have not been widely available to the farming community in the United States. Vegalab looks forward to introducing the American farmers and growers on how to improve their crops with Van Iperen and Vegalab products, while protecting the biome.”
About Vegalab, Inc.
Vegalab, Inc. is the exclusive distributor in North and South America of a line of all-natural, biologically derived pesticides, fertilizers, and specialty agricultural products. Vegalab’s pesticides are highly effective against targeted organisms, non-toxic to beneficial organisms, and safe for the environment. Vegalab’s products support a healthy soil biome and are cost competitive with synthetic chemicals that do just the opposite. The Company operates in two segments of the food industry. The Agronomy Business involves the manufacture and distribution of all-natural crop protection, crop health, and soil enhancement products: and The Packing Business is the operation of a citrus packing facility.
Van Iperen International and its partners are like a family. The company is part of the Thesis Group, a family owned business with about 100 years of experience supplying Dutch growers and producing fertilizers. We operate worldwide with our headquarters and factories in The Netherlands and subsidiaries in France, China, United States, Lebanon and Serbia.
Van Iperen International is a worldwide player, but not a multinational. We work together with local partners and operate close to our clients. Our employees represent 17 nationalities, speak 22 languages and serve clients in over 100 countries. We have crop specialists for all relevant crops and conditions in Europe as well as in (sub) tropical areas.
Safe Harbor for Forward-looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “should,” “would” or similar words. You should consider these statements carefully because they discuss our plans, targets, strategies, prospects and expectations concerning our business, operating results, financial condition and other similar matters. These statements are subject to certain risks, uncertainties, and assumptions, including, but not limited to, risks and uncertainties relating to the Company’s ability to develop, market and sell products and services, based on its technology; the expected benefits and efficacy of the Company’s products, services and technology; the availability of additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and, the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies; the ability of the Company to execute on a business plan that permits the technologies and innovations businesses to provide sufficient growth, revenue, liquidity and cash flows for sustaining the Company’s go-forward business, and the risks identified and discussed under the caption “Risk Factors” in the Vegalab Annual Report filed with the Securities and Exchange Commission (the “SEC”) and the other documents Vegalab files with the SEC from time to time. There will be events in the future, however, that Vegalab is not able to predict accurately or control. Vegalab’s actual results may differ materially from the expectations that Vegalab describes in its forward-looking statements. Factors or events that could cause Vegalab’s actual results to materially differ may emerge from time to time, and it is not possible for Vegalab to accurately predict all of them. Any forward-looking statement made by Vegalab in this press release speaks only as of the date on which Vegalab makes it. Vegalab undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.